(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of 37.71% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.47%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.91%.
Billiontoone's revenue in 2026 is $305,112,000.On average, 10 Wall Street analysts forecast BLLN's revenue for 2026 to be $20,461,221,554, with the lowest BLLN revenue forecast at $19,383,323,262, and the highest BLLN revenue forecast at $21,305,153,862. On average, 10 Wall Street analysts forecast BLLN's revenue for 2027 to be $26,633,510,789, with the lowest BLLN revenue forecast at $24,685,479,676, and the highest BLLN revenue forecast at $28,379,292,329.
In 2028, BLLN is forecast to generate $32,689,046,862 in revenue, with the lowest revenue forecast at $28,811,830,620 and the highest revenue forecast at $35,570,643,616.